CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
Year: 2011
Type: article
Study design: Case Report
Source: Cancer Immunology Immunotherapy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: MSKCC Research Center for Botanical Immunomodulators, Augmenting Cancer Vaccine Therapy with TLR9 agonists, Defining the Importance of Immunity to NY-ESO-1 in Melanoma Therapy and Prognosis, Immunization Against Melanoma Differentiation Antigens, Cancer Center Support Grant, Summer research experiences for medical students supervised by faculty mentors
OpenAlex ID: W1979446115
